ArriVent BioPharma Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
ArriVent BioPharma Inc
CIK #0001868279
EDGAR Form CIK 2011 - 2026
10-K [0001868279]
10-Q [0001868279]
3 [0001868279]
4 [0001868279]
8-K [0001868279]
D [0001868279]
SC 13D [0001868279]
SC 13G [0001868279]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Arrivent Biopharma Inc [2026-01-21]
Vanguard Group Inc Arrivent Biopharma Inc [2025-10-30]
HBM Healthcare Investments Cayman Ltd Arrivent Biopharma Inc [2025-10-15]
Infinitum Asset Management LLC Arrivent Biopharma Inc [2025-08-13]
Infinitum Asset Management LLC Arrivent Biopharma Inc [2025-05-15]
Novo Holdings A/S Arrivent Biopharma Inc [2025-02-14]
Suvretta Capital Management LLC Arrivent Biopharma Inc [2024-12-04]
HHLR Advisors Ltd Arrivent Biopharma Inc [2024-11-14]
FMR LLC Arrivent Biopharma Inc [2024-11-12]
Sofinnova Venture Partners Xi LP Arrivent Biopharma Inc [2024-11-12]
View All
Form 3/4/5 Subject 2011 - 2026
ArriVent BioPharma Inc
Hohneker John
Parsey Merdad
Nolet Chris
Peterson Kristine
Kastenmayer James Paul
Kung Winston
Yao Zhengbin
LaChapelle Robin
Lutzker Stuart
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 130,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 150,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 140,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 550,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2026-02-02 Grant 130,000 $0.00
ArriVent BioPharma Inc AVBP
Common Stock
2025-12-10 Sell 555,555 $23.37 12,983,320
ArriVent BioPharma Inc AVBP
Common Stock
2025-07-11 Option exercise 2,600 $2.28 5,928
ArriVent BioPharma Inc AVBP
Common Stock
2025-07-11 Option exercise 2,050 $2.28 4,674
ArriVent BioPharma Inc AVBP
Common Stock
2025-07-11 Option exercise 6,503 $2.28 14,827
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-07-11 Option exercise 2,600 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-07-11 Option exercise 6,503 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-07-11 Option exercise 2,050 $0.00
ArriVent BioPharma Inc AVBP
Non-Qualified Stock Option (right to buy) · derivative
2025-06-18 Grant 15,502 $0.00
ArriVent BioPharma Inc AVBP
Non-Qualified Stock Option (right to buy) · derivative
2025-06-18 Grant 15,502 $0.00
ArriVent BioPharma Inc AVBP
Non-Qualified Stock Option (right to buy) · derivative
2025-06-18 Grant 15,502 $0.00
ArriVent BioPharma Inc AVBP
Non-Qualified Stock Option (right to buy) · derivative
2025-06-18 Grant 15,502 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-04-28 Grant 28,346 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-02-03 Grant 380,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-02-03 Grant 120,000 $0.00
ArriVent BioPharma Inc AVBP
Stock Option (right to buy) · derivative
2025-02-03 Grant 120,000 $0.00
showing 20 of 64 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com